Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Meso Scale, Bio-Rad, and More

Premium

Meso Scale Discovery has released its S-PLEX immunoassay platform, which, the company said, is 1,000 times more sensitive than existing ELISA technologies and can detect analytes at concentrations below 1 femtogram per mL.

The company currently offers the platform as an assay development service, but plans in the near future to offer S-PLEX assays in kits compatible with its existing Sector and QuickPlex instruments.


Bio-Rad this week launched its Precision Plus Protein Dual Color Standards for assays including electrophoresis and western blotting. According to the company, it is the brightest protein marker available, allowing for improved monitoring of separations and estimation of protein weights.


Bioscale has launched six-plate cartridges for its VIBE acoustic assay platform, allowing researchers to obtain up to 576 data points per cartridge.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.